Family History of Colorectal Cancer Linked With Reduced Risk of Cancer Recurrence

	Tweet

Among patients with advanced colon cancer receiving treatment that includes chemotherapy, a family history of colorectal cancer is associated with a significant reduction in cancer recurrence and death, with the risk reduced further by having an increasing number of affected first-degree relatives, according to a study in the June 4 issue of JAMA.

“Approximately 16 percent to 20 percent of patients with colorectal cancer have a first-degree relative with colorectal cancer. Beyond rare but highly penetrant hereditary colorectal cancer syndromes, numerous studies have demonstrated that a history of colorectal cancer in a first-degree relative increases the risk of developing the disease by approximately 2-fold. However, the influence of family history on cancer recurrence and survival among patients with established colon cancer remains uncertain,” the authors write.

Jennifer A. Chan, M.D., M.P.H., of the Dana-Farber Cancer Institute, Boston, and colleagues examined the association of family history of colorectal cancer with recurrence and survival of 1,087 patients with stage III colon cancer who were receiving supplemental chemotherapy. Patients provided information on family history of colorectal cancer at the beginning of the study, and were followed up until March 2007 for cancer recurrence and death (median [midpoint] follow-up, 5.6 years). 

Among the 1,087 participants, 195 (17.9 percent) reported a family history of colorectal cancer in 1 or more first-degree relatives. The researchers found that a family history of colorectal cancer was associated with a significant reduction in the risk of cancer recurrence or death. Compared with patients without a family history, those with a family history had a 28 percent lower risk for cancer recurrence or death, which occurred in 57 of 195 patients (29 percent) with a family history of colorectal cancer compared with 343 of 892 patients (38 percent) without a family history.

Examining just the risk for cancer recurrence, patients with a family history of colorectal cancer had a 26 percent reduced risk compared with patients without a family history. Cancer recurrence occurred in 27 percent of patients with a family history of colorectal cancer and 35 percent of patients without a family history. The reduced risk of death for patients with a family history of colorectal cancer was 25 percent.

The apparent benefit associated with family history was stronger with an increasing number of affected family members. Compared with participants without a family history of colorectal cancer, participants with two or more affected relatives had a 51 percent lower risk for cancer recurrence or death.

“Beyond rare, well-characterized hereditary colorectal cancer syndromes, our data support the hypothesis that a relatively common though less penetrant genetic predisposition may not only influence colorectal cancer risk but also patient survival. This finding may reflect a distinct underlying molecular and pathogenic mechanism in cancers that develop in the setting of a common (i.e., sporadic) family history,” the researchers write. “Further studies are needed to more fully elucidate potential mechanisms by which a common family history may influence the outcome for patients with colorectal cancer.”

(JAMA. 2008;299[21]:2515-2523. Available pre-embargo to the media at http://www.jamamedia.org)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Editorial: Familial Colorectal Cancer - A Genetics Treasure Trove for Medical Discovery

In an accompanying editorial, Boris Pasche, M.D., Ph.D., of the Northwestern University Feinberg School of Medicine, Chicago, and Contributing Editor, JAMA, comments on the results of the study by Chan and colleagues.

“If these intriguing findings are validated in other studies, family history may well become a new prognostic factor in colorectal cancer. Should this be the case, genome-wide association studies and tumor gene expression profiling studies will be warranted to identify germline and tumor-specific genetic features associated with a family history of colorectal cancer and favorable outcome following adjuvant chemotherapy.”

“Over the past 2 decades, some of the first major molecular genetics inroads were achieved through careful study of patients with a strong family history of colorectal cancer,” Dr. Pasche writes. “The study by Chan et al suggests that family history of colorectal cancer will lead to the identification of novel genetic features predictive of response to chemotherapy. Familial colorectal cancer may therefore confirm its role as a genetics treasure trove for medical discovery.”

(JAMA. 2008;299[21]:2564-2565. Available pre-embargo to the media at http://www.jamamedia.org)

Editor’s Note: Please see the article for additional information, including financial disclosures, funding and support, etc.

Source: American Medical Association (AMA)

RELATED STORIES:
Colonoscopy used to identify and remove flat colon lesions   What’s Stopping You? Colorectal Screenings Can Prevent Cancer   Celecoxib May Help Prevent Colorectal Cancer In High Risk Patients   Exploring gender differences in colorectal cancer screenings   Abdominal fat may raise colon cancer risk   CT scans may predict survival in colorectal cancer   Folate tied to lower colon cancer risk   B Vitamins in Mother’s Diet Reduce Colorectal Cancer Risk in Offspring   Many patients not screened for colorectal cancer   Women require less tobacco exposure than men to increase colon cancer risk   Identified a cause of resistance to colon cancer treatment   Less Invasive CT-Scan Based Colorectal Cancer Screening Method Shows Good Accuracy   “Navigators” help improve colon cancer screening   Simple, personalized interventions improve colorectal cancer screening rates   Celebrex may curb colon cancer, but with caveats   Colon cancer risk in US varies by race, ethnicity   Wide Variations in Appropriateness of Rectal Cancer Surgery Across England   Morbidly obese patients face high risk for complications after colectomy   Genetic Testing May Be Valuable in Treating Colorectal Cancer   Surgery Not Necessary for Most Late-Stage Colorectal Cancers   Colon Cancer, Its Link To Diabetes, And Dietary Pattern   Pain pills may cut risk of bowel cancer: study

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]